25 min listen
Genomic Assays in Early Breast Cancer
Genomic Assays in Early Breast Cancer
ratings:
Length:
67 minutes
Released:
May 6, 2021
Format:
Podcast episode
Description
Dr Kevin Kalinsky from Emory University in Atlanta discusses the role of genomic assays in treatment decision-making for patients with hormone receptor-positive, HER2-negative, early-stage breast cancer.
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayEarlyBCGenomicAssays21).
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayEarlyBCGenomicAssays21).
Released:
May 6, 2021
Format:
Podcast episode
Titles in the series (100)
Dr Julie Gralow Comments on Breast Cancer Management in Seattle during the COVID-19 Pandemic: Dr Julie Gralow reviews how telemedicine and the screening, diagnosis and treatment of breast cancer have rapidly adapted based on resource limitations and risk factors related to COVID-19. by Oncology Today with Dr Neil Love